Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
GITR激动剂抗体TRX518单药及联合吉西他滨、帕博利珠单抗或纳武利尤单抗治疗晚期实体瘤患者的IB期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0339
Davar, Diwakar; Zappasodi, Roberta; Wang, Hong; Naik, Girish S; Sato, Takami; Bauer, Todd; Bajor, David; Rixe, Olivier; Newman, Walter; Qi, Jingjing; Holland, Aliya; Wong, Phillip; Sifferlen, Lianna; Piper, Diane; Sirard, Cynthia A; Merghoub, Taha; Wolchok, Jedd D; Luke, Jason J